XML 51 R35.htm IDEA: XBRL DOCUMENT v3.19.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2018
Share-based Compensation [Abstract]  
Summary Of Stock Options And RSUs Granted
The following is a summary of the Company's stock options and RSUs granted among the various plans:
   
Year ended
December 31, 2018
 
   
Number
of options
   
Weighted
average
exercise
price
   
Weighted average remaining contractual term
(in years)
   
Aggregate
intrinsic
value
 
                         
Outstanding at beginning of year
   
7,939,978
   
$
3.61
     
3.75
   
$
2,839
 
Granted
   
1,273,145
     
3.33
                 
Exercised
   
(1,930,244
)
   
1.44
                 
Forfeited or expired
   
(531,273
)
   
6.00
                 
                                 
Outstanding at end of the year
   
6,751,606
     
3.99
     
3.47
     
7,937
 
                                 
Options exercisable at end of the year
   
4,150,587
     
4.97
     
2.76
     
4,517
 
                                 
Vested and expected to vest
   
6,325,305
     
4.09
     
3.36
     
7,501
 
 
   
Year ended
December 31, 2018
 
   
Number of RSUs
   
Aggregate intrinsic
value
 
             
Outstanding at beginning of year
   
327,093
   
$
648
 
Granted
   
186,608
         
Exercised
   
(112,665
)
       
Forfeited
   
(24,225
)
       
                 
Outstanding at end of the year
   
376,811
     
1,424
 
                 
Vested and expected to vest
   
264,496
     
1,000
 
Summary Of Stock Options And RSUs Granted Separated Into Ranges Of Exercise Price
The following is a summary of the Company's stock options and RSUs granted separated into ranges of exercise price:

Exercise price
(range)
   
Options and RSUs outstanding
as of
December 31, 2018
   
Weighted
average
remaining
contractual
life (years)
   
Weighted
average
exercise
price
   
Options and RSUs exercisable
as of
December 31, 2018
   
Weighted
average
remaining contractual life (years for exercisable options)
   
Weighted
average
exercise
price
 
 $               
               
 
                                             
  RSUs 0.0
     
376,811
     
-
     
0.00
     
-
     
-
     
0.00
 
 
0.01-2.00
     
1,899,640
     
2.74
     
1.20
     
1,209,876
     
2.58
     
1.19
 
 
2.01-4.00
     
3,070,807
     
4.64
     
2.79
     
1,159,552
     
3.79
     
2.89
 
 
4.01-6.00
     
478,501
     
2.10
     
4.97
     
478,501
     
2.10
     
4.97
 
 
6.01-8.00
     
31,000
     
3.72
     
6.50
     
31,000
     
3.72
     
6.50
 
 
8.01-10.00
     
643,574
     
2.60
     
9.07
     
643,574
     
2.60
     
9.07
 
 
10.01-13.04
     
628,084
     
1.85
     
12.36
     
628,084
     
1.85
     
12.36
 
                                                     
         
7,128,417
                     
4,150,587
                 
Schedule Of Equity-Based Compensation Expense
The total equity-based compensation expense related to all of the Company's equity-based awards, recognized for the years ended December 31, 2016, 2017 and 2018, was comprised as follows:

   
Year ended
December 31,
 
   
2016
   
2017
   
2018
 
                   
Cost of revenues
 
$
30
   
$
54
   
$
42
 
Research and development
   
151
     
229
     
313
 
Selling and marketing
   
369
     
292
     
640
 
General and administrative
   
521
     
628
     
985
 
                         
Total share-based compensation expenses
 
$
1,071
   
$
1,203
   
$
1,980